Medical Incubator Japan

Medical Incubator Japan (MIJ) is an incubator providing investment and commercialization support services in healthcare. MIJ offers early-stage support, growth...

Medical Incubator Japan

Medical Incubator Japan (MIJ) is an incubator providing investment and commercialization support services in healthcare. MIJ offers early-stage support, growth acceleration support, commercialization support, and acceleration services. MIJ has made 10 investments, including a Seed VC investment in ILC Therapeutics on September 11, 2024, and has facilitated 2 portfolio exits, including Heartseed on July 30, 2024.

Website

medicalincubatorjapan.com

linkedin.com/company/medical-incubator-japan-k-k

General information

Firm type

Private Equity

Year founded

2018

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

Tokyo, Japan

Principals

秦充洋

代表取締役会長 / Chairman

桂淳

取締役社長 / CEO

大野元泰

取締役 / CFO

原田謙治

取締役 / Investment Officer

安江滋

取締役 / Investment Officer

駒澤明日香

Principal

唐瓏

Principal

栗原大

Principal

Sector focus

Digital HealthBiotechnology

How does Medical Incubator Japan source proprietary deal flow?

The firm emphasizes a global search capability sourced through its network of healthcare specialists. Its deal flow spans academic spinouts and early-stage biotech, often originating from university research labs. For example, portfolio company Heartseed was commercialized from seed technology developed in Professor Fukuda's laboratory at Keio University.

What investment stages does Medical Incubator Japan typically target?

The firm invests from seed and startup stage through to pre-IPO opportunities. Its portfolio includes companies at clinical trial stages, such as IgGenix (Phase 1 enrollment completed in September 2025), as well as public companies it backed earlier, including CareNet (TSE Prime), SanBio (TSE Growth), Modalis (TSE Growth), and Heartseed (TSE Growth).

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Jun 3, 2026. Continuous refresh with full update cycles at least every 30 days.